De­men­tia Dis­cov­ery Fund clos­es $350M, re­cruits Cel­gene ex­ec as CEO; Ex-Lazard banker Ian Woo joins C-Bridge and Ever­est

→ With a fresh $60 mil­lion in­vest­ment from US AARP, the De­men­tia Dis­cov­ery Fund has of­fi­cial­ly closed its $350 mil­lion fundrais­ing round. The to­tal sur­passed the group’s ini­tial tar­get of $200 mil­lion. The DDF says it’s the first and largest fund ded­i­cat­ed to de­men­tia, in­clud­ing Alzheimer’s dis­ease. The fund is man­aged by SV Health and was formed with col­lab­o­ra­tion from Bio­gen, Eli Lil­ly, GSK, J&J, Ot­su­ka (As­tex), Pfiz­er and Take­da, the UK De­part­ment of Health and So­cial Care and the char­i­ty Alzheimer’s Re­search UK. Since the group’s launch in 2015, its made 16 in­vest­ments.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.